Identifying patients at risk has obvious clinical application and the identification of relevant biomarkers associated with ADPKD CKD-development may also help to elucidate the currently obscure mechanisms linking commonly encountered mutations in the PKD1 and 2 genes to renal cysts and CKD [1]. The gene discussed is PKD1; the disease is autosomal dominant polycystic kidney disease.